1,721,300 research outputs found

    Structural profile of cardiac myxoma

    No full text
    In the 10-year period 1972-1981, 35 cardiac myxomas from 34 patients were studied. 29 tumors were surgical specimens and 6 were necropsy observations. No patient was under 10 years and only 3 were in the second decade. 25 growths were located in the left atrium, 6 in the right atrium and 2 in the right ventricle; 1 patient presented with myxomas involving both atria. The surface examined in 31 tumors appeared villous in 15, smooth in 13 and slightly irregular in 3. The tumor cells were enmeshed in Alcian blue positive mucoid material and presented as isolated, aggregated in clusters or in small cords, or lining vascular-like spaces. Ultrastructural examination performed in 9 cases disclosed a few features of endothelial cells: microvilli, cell interdigitations, desmosomes and pinocytotic vesicles; cytoplasmic organelles were usually more numerous in the cells arranged in clusters and lining spaces than in those isolated or in small cords; well-developed Golgi complex and endoplasmic reticulum were frequently observed and suggest a secretory function for the myxoma cells. The findings herein reported together with those of recent cytochemical studies support a mesenchymal origin for the myxoma cells with differentiation to endothelial line

    Calcification of valve bioprostheses: the cardiac surgeon's nightmare

    No full text
    Pericarbon is a last-generation bovine pericardial valve bioprosthesis, which was designed [I], experimentally tested [2], and introduced into clinical practice [3] in the late 1980’s with the aim of overcoming the main drawback of the Ionescu-Shiley and Vascor Hancock devices, namely mechanical tearing at the commissural level even in the absence of calcification [4-61. The early and medium-term failures observed in these first-generation pericardial valve bioprostheses were unanimously ascribed to limitations of valve design and structural properties, namely poor tissue preservation, the use of the three-leaflet model requiring excessive stitch anchorage to the commissure and tissue wear owing to friction between the leaflet and the Dacron-covered stent. To solve these problems, a single-cusp pericardial device was designed by Gabbay, which consisted of a single leaflet of glutaraldehyde-fixed bovine pericardium mounted on a flexible Delrin stent, covered by a second pericardial sheet [7]. The aims were to reduce the number of leaflet commissures at risk of tearing, to prevent contact between cloth and tissue, and to obtain the largest possible orifice area. However, despite this unquestionable rationale and promising results, both in the experimental models and initial clinical experience [8], subsequent animal [9] and clinico-pathological studies [IO] demonstrated failure of the single-cusp principle: cusp redundancy, primary commissural tears and dystrophic calcification occurred early, which suggests that this device is unsuitable as a cardiac valve substitute. Alternative solutions designed to prolong mechanical resistence at the commissures were attempted with the Carpentier-Edwards and Pericarbon pericardial bioprostheses [12], which incorporated many improvements. The Pericarbon device is characterized by a single, three-cuspal shaped pericardium sheet, which is sutured to a second sheet lining the inner surface of a low-profile, Dacron-covered Delrin frame. The two pericardial sheets are cross-sutured internally to the stents. A coating of hemocompatible Carbotilm covers all the exposed, nonbiological surfaces. The use of two pericardial sheets should allow the creation of a linkages chain with smoothly decreasing elasticity (pericardial leaflet-pericardium lining-Dacron-Delrin stent), with the aim of optimizing the stress reduction. Moreover, pericardiumto- pericardium contact should avoid leaflet abrasion

    Achilles' heel of stentless porcine valves

    No full text
    The Medtronic Freestyle is a stentless porcine valve fixed in glutaraldehyde at zero pressure and treated with α-aminoleic acid, an anticalcification agent probably acting through the mechanism of detoxification. As with other stentless valves, it was introduced to improve hemodynamics in valve replacement for aortic stenosis by reducing the transvalvular gradient and thus favoring regression of left ventricular hypertrophy. This issue of the journal reports a pathological study on nine explant

    Anticalcification strategies to increase bioprosthetic valve durability.

    No full text
    In recent years, there has been a revival in the use of bioprosthetic valves as aortic substitutes. For example, during 2008 in Germany, among 12,397 patients who underwent isolated aortic valve procedures, 78% received a biological prosthesis and 21% a mechanical valve, while only 1% underwent valve repair. However, whilst this situation is the reverse of that during the 1990s, the question must be asked as to whether this is simply a fluctuating fashion, or a reflection of other factors

    Successful treatment of cheilitis granulomatosa with intralesional injection of triamcinolone

    No full text
    A 50-year-old male patient presented to us with a permanent swelling of the upper lip, with a slight erythematic aspect, more evident at the right side; on palpation, there was an increased consistency, which felt granulose, and no pain was evoked, and the swelling had begun about 2 years ago The patient was in very good health, neither facial palsy nor fissurated tongue was present; He did not have any systemic complaints. He had been treated with oral corticosteroids and anti-histamines for a long time but without success. We performed a biopsy of the upper lip; the histological and immunofluorescence confirmed the clinical diagnosis of cheilitis granulomatosa (also called Miescher syndrome). The patients was treated with an intralesional injections of 40 mg of triamcinolone once a week for a total of three administration (Kenacort R, Bristol-Myers Squibb) with modified release associated to lidocaine 2% because the administration is very painful.8 We immediately noticed an improvement with resolution of the symptoms. Follow-up was performed at 1, 3, 6, and 12 months and no recurrence was foun

    Mixed gonadal dysgenesis: histological and ultrastructural findings in two cases.

    No full text
    Mixed gonadal dysgenesis (MGD) is an intersex genetic abnormality characterized by a streak gonad and a contralateral testis (that is typically cryptorchid) or bilateral streak testes. A uterus and one or both fallopian tubes also may be present. The external genitalia are frequently ambiguous. We studied two phenotypic "females" with MGD. One had a mosaic 45X (40%) and 46XYq (60%) karyotype, a left streak gonad, and a small testis in a right inguinal hernia, whereas the other had a 46XY karyotype, a left streak gonad, and, on the right, a testis with gonadoblastoma. On histological and ultrastructural examination the testis in the first case showed prepubertal tubules lined by a few spermatogonia and immature Sertoli cells with asynchronism in nuclear-cytoplasmic maturation. Ultrastructural examination of the gonadoblastoma in the second case showed neoplastic Sertoli cells. Irregular maturation of Sertoli cells appears to be a feature of MGD. Gonadal extirpation and pathological examination in these cases are important in order to make the correct diagnosis and prevent neoplastic changes

    Toronto porcine stentless valve and the need for something more

    No full text
    Stentless valves were greeted as a great step forward for the replacement of diseased aortic valves, particularly aortic valve s ten osis i n t he e lde rly. In 19 88, Ti rone Da vid developed a stentless xenograft (Toronto Stentless Porcine bioprosthesis) aimed to improve hemodynamics, valve durabi lity, a nd pati ent survi val [1]. This stent less valve truly resembles a human aortic valve, with cusps, commissures, and aortic wall posts. The lack of a frame greatly improves functional performance by diminishing postoperative transvalvular gradient, thus favoring regression of left ventricular hypertrophy and enhancing cardiac electrical stability. Recent study has confirmed that low gradients and large effective orif ice area are mai ntained at nine years after implant atio
    corecore